Lymph Node Genesis Is Induced by Signaling through the Lymphotoxin β Receptor  by Rennert, Paul D. et al.
Immunity, Vol. 9, 71±79, July, 1998, Copyright 1998 by Cell Press
Lymph Node Genesis Is Induced by Signaling
through the Lymphotoxin b Receptor
and also Peyer's patches but retained mesenteric, cervi-
cal, and sacral LN (Alimzhanov et al., 1997; Koni et al.,
1997).
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have not demonstrated that LTb-R is the receptor sig-Biogen, Incorporated
naled by the LTab ligand to induce LN genesis. This isCambridge, Massachusetts 02142
of particular importance since LT and TNF ligands bind
multiple receptors, so alternative ligand/receptor inter-
actions could explain the different LN phenotypes mani-
Summary fested in LTa2/2 and LTb2/2 mice. Human LTa homotri-
mers bind to TNF-R55 and TNF-R75 and with an
apparent lower affinity to the HSV cellular receptorWe investigated lymphotoxin (LT) and TNF function
HVEM (Ware et al., 1995; Aggarwal and Natarajan, 1996;in lymph node genesis and cellular organization by
Mauri et al., 1998). Likewise, murine recombinant LTamanipulating LTb-R and TNF-R signaling. Lymph nodes
binds mouse TNF-R55, although with 1,000- to 10,000-developed in LTa2/2 mice treated in utero with agonist
fold less potent activity (Browning et al., 1997). The pre-anti-LTb-R monoclonal antibody. Thus, LTb-R signal-
dominant human heteromeric LTab complex LTa1b2ing mediates lymph node genesis. Surprisingly, muco-
binds LTb-R, as does the newly described TNF familysal lymph nodes that can develop independently of
ligand LIGHT, which itself is also a ligand for HVEMLTab/LTb-R interaction were generated. Normal mice
(Crowe et al., 1994; Browning et al., 1995; Mauri et al.,treated in utero with LTb-R-Ig and TNF-R55-Ig or anti-
1998). The minor human form LTa2b1 binds to TNF-R55TNF lacked all lymphnodes, indicating that TNF signal-
and TNF-R75 and weakly to LTb-R (Browning et al.,ing contributes to lymph node genesis. Lymph nodes
1996; J. L. B., unpublished data). Mouse LTb-R is pre-generated in LTa2/2 mice had disrupted cellular orga-
sumed to bind mouse LTab ligands similarly (Browningnization. Therefore, LTb-R signaling during gestation
et al., 1997; Mackay et al., 1997b). Thus, there is theis not sufficient to establish normal cellular microar-
potential for multiple ligands to interact with LTb-R andchitecture. We conclude that LT and TNF play critical
for heteromeric receptor clustering by individual ligands,roles in the genesis and cellular organization of lymph
as recently described for the TNF receptors (Pinckard etnodes.
al., 1997). It is not known whether other ligand/receptor
interactions contribute to LN genesis. Complicating the
Introduction analysis of pathways of LN genesis is the incomplete
penetrance of the knockout phenotypes, as shown by
Genetic deletion of the mouse lymphotoxin alpha (LTa) the occasional presence of mesenteric and cervical LN
gene resulted in a striking phenotype characterized by in LTa2/2 mice and the occasional absence of any LN
the absence of lymph nodes (LN) and Peyer's patches, in one colony of LTb2/2 mice (De Togni et al., 1994;
providing evidence that LT ligands signal the genesis Banks et al., 1995; Alimzhanov et al., 1997).
of peripheral lymphoid organs (De Togni et al., 1994; The in utero blockade experiments and the analyses
Banks et al., 1995). Since LN and Peyer's patches were of LTa2/2, LTb2/2, TNF2/2, and TNF-R552/2 mice also
retained in TNF-R552/2 and TNF-R752/2 mice (Pfeffer et do not directly address whether LT and TNF ligand/
al., 1993; Rothe et al., 1993; Erickson et al., 1994), the receptor interactions have additional roles in establish-
signaling pathway was thought to be independent of ing and/or maintaining cellular organization in adult sec-
homotrimeric LTa and TNF binding to the TNF receptors ondary lymphoid tissues. Data from LTa2/2, TNF-R552/2,
(TNF-R). It was therefore hypothesized that the mem- TNF2/2, and LTb2/2 mice have demonstrated that per-
brane-bound heterotrimeric LTab protein signaled its manent interruption of LT and/or TNF signaling caused
unique receptor, LTb-R, to mediate LN genesis (Crowe disruption in splenic marginal zone, lymphocyte, and
et al., 1994; Erickson et al., 1994; Ware et al., 1995). Our follicular dendritic cell (FDC) organization and germinal
previous studies showing that LN genesis was disrupted center (GC) formation (reviewed in Liu and Banchereau,
by in utero blockade of LTab using LTb-R-Ig fusion pro- 1996; Matsumoto et al., 1997a; von Boehmer, 1997).
tein or anti-LTb MAb supported this hypothesis (Rennert Importantly, antagonism of LTab interactions using sol-
et al., 1996). However, LTb-R-Ig treatment in utero did uble LTb-R-Ig or anti-LTb MAb treatment in adult
BALB/c mice caused disruptions in splenic T/B organi-not block development of a subset of mucosal LN, in-
zation, marginal zone integrity, and FDC networks thatcluding the mesenteric, cervical, lumbar, and sacral
were very similar to that seen in the LTa2/2 mice (Mackaynodes, suggesting the existence of an LTab indepen-
et al., 1997a; Mackay and Browning, 1998). These stud-dent pathway of LN genesis (Rennert et al., 1996, 1997).
ies showed that LTab is critical for the maintenance ofThis interpretation was supported by the description of
cellular organization in the adult spleen. Similar conclu-the phenotype of LTb2/2 mice, which lacked most LN
sions can be drawn from studies showing that wild-type
bone marrow transplantation restores normal cellular
architecture to the spleen of LTa2/2 mice (Matsumoto*To whom correspondence should be addressed (e-mail: Paul_
Rennert@Biogen.com). et al., 1997b).
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It appears that lymphoid architecture is not controlled
by one unique mechanism in all secondary lymphoid
organs. In fact, the function of LT and TNF ligands in
mediating cellular organization in LN is not well under-
stood. Deletion or antagonism of the TNF/TNF-R55
pathway induced alterations in LN cellular populations
that were similar to those observed in spleen, including
a lack of organized FDC networks and disrupted B cell
follicles (Fu et al., 1997; Pasparakis et al., 1997; Rennert
et al., 1997). Despite this altered cellular organization,
LN in TNF-R552/2 mice and in mice treated throughout
life with a TNF-R55-Ig fusion protein supported GC for-
mation (Pasparakis et al., 1997; Rennert et al., 1997). LN
in mice expressing a TNF-R55-Ig transgene lacked B
cell follicles and had displaced FDC networks (Ettinger
et al., 1998). These studies have identified a role for the
Figure 1. LTb-R-Specific MAb AF.H6 Has Antiproliferative ActivityTNF/TNF-R55 pathway in maintaining B cell follicular
on Human WiDr Cellsstructure and FDC networks in LN, as in spleen, but also
WiDr cells were grown for 4 days in the presence (circles) or absencesuggested different requirements for GC formation in
(squares) of 50 U/ml interferon-g with a control hamster MAb (open)these two lymphoid compartments.
or AF.H6 (closed) at the indicated concentrations. Interferon-g alone
Evidence that LT ligands function in establishing and has a slight antiproliferative effect and reduced the absorbance from
maintaining LN cellular organization has come from 1.3 to 0.9.
analyses of the single mesenteric LN that occasionally
develops in LTa2/2 mice and from LTb2/2 mice, which
retain mesenteric, cervical, and sacral LN. In these mice, was suggestive of mixed agonistic/antagonistic behav-
the organization/phenotype of LN B cell, high endothe- ior, similar to that previously described for antibodies
lial venule (HEV), and macrophage populations has been specific for TNF family receptors (Ledbetter et al., 1995;
variably described as normal (Fu et al., 1987; Koni et Browning et al., 1997). In such cases, an antibody can
al., 1997) or disrupted (Banks et al., 1995; Alimzhanov
block ligand binding and thus receptor signaling but
et al., 1997). Both LTa2/2 and LTb2/2 mice lack FDC
also effectively cross-link receptor in the absence of
networks, as do TNF2/2 and TNF-R552/2 mice (Fu et al.,
ligand and act as an agonist (Ledbetter et al., 1995).
1997; Pasparakis et al., 1997). B cell, HEV, and macro-
Alternative mechanisms may exist that involve MAb af-
phage populations were unaffected in LN of adult mice
finity and relative receptor density (Fadeel et al., 1997).
treated with LTb-R-Ig fusion protein or in mice express-
The ability of anti-murine LTb-R MAbs AC.H6 and
ing an LTb-R-Ig transgene after birth (Ettinger et al.,
AF.H6 to act alone as agonists was tested on the murine
1996; Mackay et al., 1997a), even though FDC networks
WEHI 164 and human WiDr cell lines, as these hamster
were displaced or absent (Ettinger et al., 1998; Mackay
MAbs cross-reacted with human LTb-R (J. L. B., unpub-and Browning, 1998). Thus, while LT ligands appear
lished data). WiDr cells were grown for 4 days in thecritical for LN genesis, it is not known to what extent
presence or absence of interferon-g with a control ham-LT is required for the establishment and maintenance
ster MAb Ha4/8 or anti-LTb-R MAb AF.H6 and then ana-of LN cellular organization in the adult.
lyzed for the extent of cell death. AF.H6 signaled WiDrWe have created a novel model to study LN genesis
cells to inhibit cell growth in an interferon-g-dependentand cellular organization by utilizing an agonist anti-
manner, even without MAb immobilization (Figure 1).LTb-R MAb in utero to reverse the genetic defect in
Neither soluble nor plastic-immobilized AC.H6 orLTa2/2 mice. Using these mice, which have LN but lack
AF.H6 induced WEHI 164 death, perhaps due to ineffec-critical molecular interactions, we have examined the
tive immobilization/orientation of the hamster MAb.roles of the LTb-R and TNF-R pathways in LN genesis
Therefore, we evaluated MAb signaling of WEHI 164and in mediating LN cellular organization.
cells by measuring murine LTb-R expression, as ligand-
induced receptor down-regulation is commonly ob-
served in the TNF-Rfamily (Higuchi and Aggarwal,1994).Results
Using FACS analysis, murine LTab ligand binding was
found to down-regulate LTb-R on L929 and WEHI 164Activity of Agonistic Anti-LTb-R MAbs
mouse cells (J. L. B., unpublished data). In experimentsPreviously, immobilized anti-human LTb-R MAbs were
using MAbs, the mean fluorescence channel of intensityshown to induce the death of human adenocarcinoma
(MFCI) of LTb-R staining on WEHI 164 cells was 77 whenWiDr cells in an interferon-g-dependent process (Brown-
untreated, 67 when incubated with control MAb Ha4/8,ing et al., 1996). Therefore, hamster anti-murine LTb-R
and 20 when incubated with anti-LTb-R MAb AF.H6 asMAbs, which block soluble murine LTab-induced death
assessed using biotinylated AC.H6, which binds a non-of the murine fibroblastoid line WEHI-164 (Mackay et
overlapping epitope. Thus, MAb AF.H6 specifically in-al., 1997b), were evaluated for agonist activity as well.
duced LTb-R down-regulation. VCAM-1 expression wasMAb AC.H6, which effectively blocked LTab-induced
also increased on WEHI 164 cells, albeit weakly (2- tocell death, also paradoxically potentiated TNF signaling
of these same cells (Mackay et al., 1997b). This pattern 3-fold), when stimulated by murine LTab ligand (J. L. B.,
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Table 1. In Utero Treatment with Agonist Anti-LTb-R MAb Induces LN Formation in LTa2/2 Micea
Initial Gestational
MAb Specificity Day Treated Litters (#) Progeny (#) LN Identified
Ha/48 KLH 13 4 12 None
BB.F6 LTb 13 2 5 None
AF.H6 LTb-R 12±13 6 17 Mandibular, cervical, brachial, axillary, cranial
and caudal mesenteric, iliac, sacralb
AF.H6 LTb-R 14±15 3 11 Mandibular, cervical, brachial, axillary, caudal
mesenteric, iliacb
AF.H6 LTb-R 16 1 4 Axillary
AF.H6 LTb-R 17 1 3 None
a Pregnant LTa2/2 mice were injected i.v. with 250 mg MAb on the gestational day indicated and every 48 hr afterward. Pregnant mice were
not treated after gd 17. Presence or absence of LN was identified in the progeny at 4 weeks of age.
b Inguinal and popliteal LN were identified in two pups from one litter treated with AF.H6 beginning on gd 13 and in two pups from one litter
treated with AF.H6 beginning on gd 14.
unpublished data), or MAbs AF.H6 and AC.H6. In experi- gd 16 resulted in no LN being formed (Table 1). In gen-
eral, secondary lymphoid tissues known to develop latements using MAbs, the MFCI of staining with rat anti-
VCAM-1 MAb 429 on WEHI 164 cells was 145 and 150 in gestation or at the time of birth (inguinal and popliteal
LN, Peyer's patches) did not form in the anti-LTb-R-when unstimulated or incubated with Ha4/8, respec-
tively, but was increased to 223 and 331 when incubated treated progeny. This suggests that as MAb AF.H6
cleared from circulation following the final treatment,with LTb-R-specific MAbs AF.H6 and AC.H6, respec-
tively. Collectively, these data indicate that AF.H6 and signaling through LTb-R dropped below a threshold
necessary to support LN genesis. This sequence of pe-AC.H6 can directly signal through LTb-R in the absence
of LTab ligand. ripheral LN development was consistent with results
from normalmice in which LN development was blocked
with LTb-R-Ig fusion protein (Rennert et al., 1996). LN
LTb-R-Specific MAb Induced Embryonic
were not induced to form in progeny born to pregnant
Genesis of LN LTa2/2 mice treated with control MAbs (Table 1). These
The generation of an agonist MAb specific for LTb-R
results formally show that signaling through LTb-R is
allowed us to directly evaluate the role of this receptor
sufficient to induce LN genesis and demonstrate that a
in the genesis of LN. In these experiments, pregnant
phenotype caused by a genetic deletion can be perma-
LTa2/2 mice were treated with agonist anti-LTb-R MAb
nently reversed by in utero signaling with a specific
AF.H6, control MAb Ha4/8, or anti-LTb MAb BB.F6 in
agonist MAb.
utero beginning on gestational day (gd) 12 or 13 and
every 48 hr thereafter until gd 17. These hamster MAbs
were detected by ELISA in the plasma of the progeny
of treated pregnant mothers immediately after birth, with
AF.H6 typically present at a much lower level than BB.F6
or Ha4/8, consistent with the rapid clearance of AF.H6
from mouse circulation (Rennert et al., 1996; data not
shown). Examination of 17 progeny from 6 litters born
to anti-LTb-R-treated LTa2/2 mothers showed that man-
dibular, cervical, brachial, axillary, mesenteric, iliac, and
sacral LN had been induced to develop (Table 1; Figure
2). Additional induction experiments in which treatment
with anti-LTb-R MAb in utero was initiated on different
gestational days suggested an order of development
of LN. The mesenteric LN appeared to develop in two
distinct phases, with cranially placed nodes developing
prior to caudally placed nodes. Progeny born to mothers
treated with anti-LTb-R beginning on gd 12 or 13 repro-
ducibly developed as many as six mesenteric LN and
sacral LN (Table 1), while those treated beginning on gd
14 or 15 had at most three mesenteric LN and no sacral
LN. Peripheral LN development also depended on the
gestational day that treatment commenced, since treat-
Figure 2. An Agonist LTb-R-Specific MAb Delivered In Utero In-
ment beginning on gd 12±14 induced the formation of duces LN Genesis in LTa2/2 Mice
mandibular, brachial, axillary, and iliac LN, while treat-
Shown are brachial (A and B) and mesenteric (C and D) LN in adult
ment beginning on gd 15 failed to induce genesis of LTa1/1 mice (A and C) and in 4-week-old LTa2/2 mice (B and D) that
brachial and iliac LN in some litters. Treatment on gd had been treated with 250 mg of anti-LTb-R MAb AF.H6 in utero on
gestational days 13, 15, and 17.16 induced axillary LN genesis only, and treatment after
Immunity
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LN Development In Utero Was Blocked by Combined
Dosing with LTb-R-Ig and Either
TNF-R55-Ig or Anti-TNF MAb
The induction of both peripheral and mucosal LN in
LTa2/2 mice treated in utero with an agonist anti-LTb-R
MAb was interesting, since in utero treatment with LTb-
R-Ig failed to block the development of mesenteric, cer-
vical, sacral, and lumbar (ie., mucosal) LN in normal mice
(Rennert et al., 1996, 1997). To determine which LT or
TNF ligands and receptors function in LN genesis, we
treated pregnant normal mice with LTb-R-Ig and TNF-
R55-Ig fusion proteins beginning on various gestational
days and at 72 hr intervals thereafter. Surprisingly, al-
though the development of mucosal LN could not be
prevented by treating pregnant mice with as much as
400 mg of LTb-R-Ig or 400 mg of TNF-R55-Ig alone, the
genesis was blocked using the combination of 100 mg
of TNFR55-Ig and 100 mg of LTb-R-Ig. In these mice, the
development of all LN, including mesenteric, cervical,
sacral, and lumbar, was ablated (Figure 3; Table 2). The
ability to block the genesis of mucosal LN depended on
the gestational day on which treatment commenced.
Treatment with 100 mg each of LTb-R-Ig and TNF-R55-
Ig on gd 11 was required to ablate all LN development,
with greater numbers of mesenteric LN remaining in
progeny born to mice treated progressively later in preg-
nancy (Table 2). The block in development of mesenteric
LN appeared to have two distinct phases, with the cra-
nial group of mesenteric LN developing prior to the cau-
dal group (data not shown). Finally, the single most cra-
nial mesenteric LN often developed even in mice treated
in utero as early as gd 11. To demonstrate that the block
in mucosal LN development was specific, pregnant mice
were dosed beginning on gd 11 with 100 mg each of
LTb-R-Ig and LFA-3-Ig. All of the progeny examined had
mucosal LN (data not shown).
To directly examine the potential role of TNF signaling
in LN genesis, 100 mg of LTb-R-Ig fusion protein was
administered to pregnant mice in combination with 250
mg of anti-TNF MAb TN3, beginning on day 11 of gesta-
tion. TN3 can be detected in the plasma of the progeny
on the day of birth, indicating successful transfer of Figure 3. Development of All LN in Wild-Type Mice Can Be Ablated
the MAb into the developing progeny (data not shown). by Embryonic Treatment with Both LTb-R-Ig and TNF-R55-Ig Fusion
ProteinsConcommitant blockade of TNF and of LTab resulted
Iliac and sacral LN are present in mice treated in utero with LFA-3-in the ablation of all LN development, mimicking the
Ig fusion protein (A); sacral LN remain in mice treated in utero withresults of dual TNF-R55-Ig/LTb-R-Ig treatment (Table
LTb-R-Ig fusion protein (B) but are absent in mice treated in utero2). The ability to block LN genesis using TN3/LTb-R-Ig
with both LTb-R-Ig and TNF-R55-Ig fusion proteins (C). BALB/c
treatment was temporally regulated in the same manner mice were treated in utero with 100 mg of LFA-3-Ig, 100 mg of LTb-
as TNF-R55-Ig/LTb-R-Ig treatment (Table 2). Thus, TNF R-Ig, or 100 mg each of LTb-R-Ig and TNF-R55-Ig fusion proteins
can deliver a signal for LN genesis during gestation. on gd 11, 14, and 17.
with anti-LTb-R MAb AF.H6 beginning on gd 12 or 13LT and TNF Ligands Mediate LN
Cellular Organization to induce the formation of LN. Since thehalf-life of AF.H6
in adult mouse circulation is approximately 1 day (J. L. B.,The in utero treatment strategy allowed us to investigate
whether signaling by LT ligands during gestation is suffi- unpublished data), and dosing occurs only until gd 17,
AF.H6-induced LTb-R signaling is probably very tran-cient not only for LN genesis but also to establish the
LN cellular organization thought to support immune re- sient. Four to six weeks after birth, we performed immu-
nohistochemical analyses of the LN that had been in-sponses in peripheral lymphoid organs of adult mice.
To evaluate the role of LT ligands in establishing LN duced to form in LTa2/2 mice. All LN that had developed
in LTa2/2 mice were characterized by the localization ofcellular organization, we examined the cellular popula-
tions and immune responsiveness of LN induced to de- B cells in a thin zone that appeared coincident with the
subcapsular sinus and segregated from the T cell areavelop in LTa2/2 mice. LTa2/2 mice were treated in utero
LTb-R Mediates Lymph Node Genesis
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Table 2. Development of All LN in Wild-Type Mice Can Be Ablated by Treatment In Utero with the Combination of LTb-R-Ig and
TNF-R55-Ig or Anti-TNF MAb
Initial Gestational
Reagent day Treated mg Dosed Litters (#) Progeny (#) LN Identifiedb
LFA-3-Ig 11 400 2 6 6±8 mesenteric, sacral, cervical, pLNb
TNF-R55-Ig 11 100 2 6 6±8 mesenteric, sacral, cervical, pLN
TNF-R55-Ig 11 400 3 6 6±8 mesenteric, sacral, cervical, pLN
LTb-R-Ig 11 100 7 18 6±8 mesenteric, sacral, cervical
LTb-R-Ig 11 400 2 6 6±8 mesenteric, sacral, cervical
TNF-R55-Ig/LTb-R-Ig 11 100 ea 4 11 0±1 mesenteric
TNF-R55-Ig/LTb-R-Ig 12±13 100 ea 2 6 2±4 mesenteric, sacral
TNF-R55-Ig/LTb-R-Ig 14 100 ea 4 17 2±6 mesenteric, sacral, cervical
TNF-R55-Ig/LTb-R-Ig 15 100 ea 2 5 6±8 mesenteric, sacral, cervical,
brachial, axillary
Anti-TNF/LTb-R-Ig 11 250 MAb/100 protein 2 8 0±1 mesenteric
Anti-TNF/LTb-R-Ig 12 250 MAb/100 protein 2 7 2 mesenteric, sacral
a Pregnant BALB/c female mice were injected i.v. with the indicated dose of fusion proteins or MAb, followed by additional doses every 72
hr. Pregnant mice were not treated after gd 17. Presence or absence of LN was determined in the progeny at 4 weeks of age.
b LN examined were peripheral LN (pLN) (mandibular, cervical, brachial, axillary, inguinal, popliteal, and iliac) and mucosal LN (cervical,
mesenteric, and sacral).
(Figures 4Aand 4B). In addition, sialoadhesin expression of C57Bl/6 mice with LTb-R-Ig, TNF-R55-Ig, and LFA-
3-Ig produced immunohistochemical results identicalon macrophage populations within the subcapsular si-
nus was markedly down-regulated, as was PNAd ex- to those obtained using BALB/c mice. Taken together,
these results suggest that postgestational LTab/LTb-Rpression onperipheral LN HEV and both PNAd and MAd-
CAM-1 expressionon mesenteric LN HEV (Figures4C±4F). interaction is critical for the establishment of cellular
organization in LN, including the formation of B cellFDC were absent, as shown by the loss of staining for
FDCM1 (data not shown) and FDCM2 (Figures 4G and follicles. However, once established, B cell follicle integ-
rity in LN depends on signals through TNF-R rather than4H). These results suggest that LTb-R signaling caused
by treatment with anti-LTb-R MAb during gestation is LTb-R. In contrast, FDC networks in LN require signals
through both pathways to be maintained.not sufficient to establish the cellular organization within
LN. Despite the disruption in B cell and FDC populations,
mesenteric LN induced to develop in LTa2/2 mice formed Discussion
GC (presumably in response to environmental antigens),
as assessed by positive peanut agglutinin (PNA) staining Using a novel strategy of maternal transfer, we have
shown that delivery of an agonist anti-LTb-R MAb to(data not shown).
To further examine the relative role of LTb-R and TNF- developing LTa2/2 mice induces the formation of LN.
While manipulationof receptor signaling in vivovia injec-R55 pathways in maintaining cellular organization in LN
of adult mice, we treated 6- to 8-week-old BALB/c and tion of adult mice with agonist MAb is well established
for TNF-R family members (Ogasawara et al., 1995; TianC57Bl/6 mice every 72 hr with 100 mg of receptor-Ig
fusion proteins (for 10 days) or 200 mg of MAbs (for 7 et al., 1995; Shuford et al., 1997), this demonstrates that
agonist signaling can permanently reverse a develop-days). Peripheral lymphoid organs were harvested 24
hr after the final injection. Immunohistological examina- mental defect caused by genetic deletion. Furthermore,
our results show that the formation of all LN can betion of T/Bcell organization in LNof normaladult BALB/c
mice treated with TNF-R55-Ig fusion protein showed mediated via signaling through LTb-R and indicate that
this pathway plays a dominant role in LN genesis. Sincethat B cells lose their typical follicular localization (Figure
5), a phenotype similar to that observed in the spleen LTa2/2 mice lack essentially all LN (De Togni et al., 1994;
Banks et al., 1995), this suggests that LN development(data not shown). Treatment with the anti-TNF-specific
MAb TN3 induced a similar, although less marked, phe- is mediated by the interaction of LTab ligand with LTb-R.
This result extends our previous studies in which LNnotype (Figure 5). Neither the LTa-specific MAb AF.B3
nor control MAb Ha4/8 disrupted B cell follicular local- development was blocked using LTb-R-Ig fusion protein
(Rennert et al., 1996, 1997).ization (Figure 5), suggesting that TNF is the relevant
ligand that engages TNF-R tomaintain LN B cell follicles. These studies have produced a puzzling contradic-
tion, as the results show that all LN can be induced toTreatment of adult BALB/c mice with LTb-R-Ig or control
LFA-3-Ig appeared to have no effect on T/B cellular form via signaling through LTb-R, but not all LN forma-
tion is ablated by blocking LTab/LTb-R engagementorganization, sialoadhesin expression, or HEV differenti-
ation in LN (Figure 5; data not shown), although FDC during development. That these differences mimic those
observed between the LTa2/2 and LTb2/2 mice furtherstaining was ablated after LTb-R-Ig treatment (Mackay
and Browning, 1998). This contrasts with observations complicates the synthesis of the available data. To un-
tangle the ligand/receptor interactions that account foron the spleen from LTb-R-Ig-treated adult BALB/c mice,
which had disrupted marginal zones, FDC, and B cell the genesis of mucosal LN (mesenteric, cervical, lumbar,
and sacral) that are observed in mice treated with LTb-populations, as has been recently described (Mackay
et al., 1997a; Mackay and Browning, 1998). Treatment R-Ig in utero and in LTb2/2 mice (Rennert et al., 1996,
Immunity
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Figure 5. Antagonism of the TNF-R55 but Not the LTb-R Pathway
in Normal Adult Mice Disrupts the Maintenance of Cellular Organiza-
tion in LN
Normal adult mice were treated i.p. with purified fusion proteins for
10 days or with MAbs for 7 days starting at 6 weeks of age, and
Figure 4. Embryonic Signaling of LTb-R Is Insufficient to Establish
then LN were harvested for analysis of cellular organization in LN.
or Maintain the Cellular Organization within LN Induced to Form in
Axillary LN from LFA-3-Ig (A), TNF-R55-Ig (B), LTb-R-Ig (C), MAb
LTa2/2 Mice
Ha4/8 (D), MAb TN3 (E), and MAb AF.B3 (F) treated normal adult
Shown are immunohistochemical analyses of representative bra- mice were stained with antibodies to B220 (green) and CD4 (red).
chial LN from LTa1/1 mice (A, C, E, and G) and induced to form in
LTa2/2 mice (B, D, F, and H). LN were dissected from 4-week-old
genesis in utero, TNF/TNF-R engagement can providemice and stained with antibodies to B220 ([A and B], green), CD4
a signal for the genesis of mucosal LN. The latter path-([A and B], red), PNAd (C and D), sialoadhesin (E and F), and FDCM2
(G and H). way is not distinguished in TNF-R2/2 or TNF2/2 mice,
since LTb-R signaling is the dominant pathway for gene-
sis of all LN, but is clearly revealed when the dominant
1997; Alimzhanov et al., 1997; Koni et al., 1997), we pathway is blocked. The phenotype of the LTa2/2 mouse,
employed a combination of antagonist receptor-Ig fu- which lacks all LN, suggests additional complexity.
sion proteins and blocking MAbs. Although previous However, the accumulated data show that signaling by
studies using receptor blockade or knockout mice had TNF can induce mucosal LN formation, although other
indicated that TNF or LTa3 interactions with TNF-R are variables may influence the efficacy of this pathway.
not necessary for LN genesis (Pfeffer et al., 1993; Rothe This model provides an explanation for the incomplete
et al., 1993; Erickson et al., 1994; Pasparakis et al., 1996; penetrance of the knockout phenotypes of both the
Rennert et al., 1996), we have now shown that treatment LTa2/2 and LTb2/2 mice (De Togni et al., 1994; Banks
of normal mice in utero with LTb-R-Ig and TNF-R55-Ig et al., 1995; Alimzhanov et al., 1997; Koni et al., 1997).
effectively blocked the development of all LN. Since The occasional mesenteric and cervical LN found in
results from LTb2/2 mice showthat mucosal LN can form LTa2/2 mice may form due to TNF binding to TNF-R,
in the absence of LTb-containing ligands (Alimzhanov et although this interaction is clearly insufficient to induce
al., 1997; Koni et al., 1997), and the available biochem- the formation of all mucosal LN. It is unclear why this
ical evidence indicates that LTa3 cannot bind LTb-R in is so; however, an examination of TNF levels in LTa2/2
either the human or murine systems (Crowe et al., 1994; mice may provide some insight (Alexopoulou et al, 1998).
Browning et al., 1995, 1997), the simplest interpretation Similarly, in one colony of LTb2/2 mice, only 75% of
of the available data is that in the absence of LTb-R mice have mucosal LN (Alimzhanov et al., 1997), sug-
signaling a TNF-R-dependent pathway mediates muco- gesting that TNF-R can signal to induce mucosal LN
sal LN genesis. Specifically, LTab signals LTb-R to in- genesis but also showing that this interaction is insuffi-
duce the formation of peripheral and mucosal LN, and, cient to fully induce mucosal LN formation in the ab-
as shown by our results using anti-TNF MAb TN3 and sence of LTb-containing ligands. It is not known if TNF
expression is compromised in LTb2/2 mice.LTb-R-Ig fusion protein in combination to block all LN
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A preliminary report of the loss of all LN in the LTb- Fu et al., 1997; Tkachuk et al., 1998). In these mice, the
R2/2 mouse (Alimzhanov et al., 1997; FuÈ tterer et al, 1998 loss of B cell follicular organization was coincident with
[this issue of Immunity]) appears to be inconsistent with the loss of FDC networks. Furthermore, LN and splenic
the model we have presented, unless the TNF-R path- cellular organization was similarly affected, showing that
way of LN genesis requires LTb-R/TNF-R heterocom- these lymphoid organs have similar requirements for
plex formation or receptor clustering. Although TNF- TNF-R signaling to maintain B cell follicular organization
R55/TNF-R75 heterocomplexes have been observed and FDC networks. As expected given the phenotype
(Pinckard et al., 1997), LTb-R-containing heterocom- of the TNF2/2 mouse, B cell follicular organization was
plexes have not been described.However, LTb-R activa- also disrupted by treatment with the anti-TNF MAb TN3,
tion by an agonist MAb can potentiate signaling by TNF, although to a lesser extent, possibly due to the shorter
suggesting that cooperative signaling between the TNF- course of treatment (7 versus 10 days). These data dem-
R55 and LTb-R pathways can occur in both the human onstrate that the disruption in splenic and LN cellular
and murine systems (Browning et al., 1996, 1997). organization observed in mice with blocked TNF/TNF-R
Other pathways for LN genesis have been hypothe- engagement reflects the interruption of ongoing physio-
sized. For example, our results do not exclude the logical processes rather than arrested tissue develop-
involvement of an LTa3/HVEM pathway in LN genesis ment as recently postulated (Ettinger et al., 1998).
(Mauri et al., 1998). It is also possible that a novel LTa While themechanisms that direct the establishment of
ligand signals through LTb-R or an LTb-R signaling com- cellular microarchitecture in secondary lymphoid organs
plex to induce the formation of mucosal LN, but in a are not understood, the recent identification of chemo-
manner that cannot be blocked by soluble LTb-R-Ig tactic agents expressed in LN and at high levels on
fusion protein. Finally, the recently described ligand HEV suggests possible signaling networks that could
LIGHT, which shares significant homology with LTb and be disrupted in LTa2/2 and LTb2/2 mice (Forster et al.,
binds specifically to LTb-R as a homotrimer (Mauri et 1996; Adema et al., 1997; Yoshie et al., 1997; Gunn et
al., 1998), could induce the genesis of the occasional al., 1998; Legler et al., 1998). It is intriguing to note
single mesenteric LN found in LTa2/2 mice. However, that BLR-12/2 mice show a pattern of B cell follicular
our results using TNF-R55-Ig or anti-TNF in combination disruption that more closely resembles that of adult mice
with LTb-R-Ig to ablate all LN formation suggest that treated with LTb-R-Ig rather than TNF-R55-Ig; that is,
such pathways do not normally mediate LN genesis.
the capacity of B cells to form follicles is normal in LN
Although the receptor agonist strategy showed that
but not in spleen in these mice (Forster et al., 1996). It
LTb-R signaling is the dominant pathway for LN genesis,
may be that the BLR-1 chemotactic pathway is depen-
our examination of peripheral and mucosal LN that de-
dent on the LTab/LTb-R pathway and not the TNF/TNF-
veloped in LTa2/2 mice shows unambiguously that ges-
R55 pathway as has been speculated (Goodnow and
tational signaling through LTb-R is not sufficient for the
Cyster, 1997).establishment and maintenance of normal LN cellular
In summary, the novel strategy of maternal transferorganization. The near total loss of addressin and sialo-
has allowed us to show that signaling through LTb-Radhesin expression on HEV and macrophages, respec-
provides the dominant pathway for LN genesis and thattively, and the dissolution of B cell follicles and FDC
signaling through TNF-R can provide a redundant path-networks suggest that critical signals that would nor-
way for mucosal LN genesis. Furthermore, LTb-R signal-mally direct the establishment of fully developed mi-
ing is critical during neonatal life for the establishmentcroarchitecture in LN are absent in LTa2/2 mice. The
of cellular architecture in LN and acts distinctly fromdevelopmental window during which LN cellular archi-
TNF-R in maintaining lymphocyte and FDC populationstecture is established may be very narrow, since B cell
in the spleen and LN of the secondary lymphoid system.follicles are apparent 4 days after birth (Mebius et al.,
1997). Expression of an LTb-R-Ig transgene beginning
Experimental Procedures3 days after birth did not appear to disrupt LN cellular
organization, although this may have been due to insuffi-
Animals
cient protein expression (Ettinger et al., 1996). Likewise, All animals were housed under conventional barrier protection and
our studies of LTb-R-Ig antagonism in adult BALB/c or handled in accordance with institutional guidelines. LTa2/2 and
C57Bl/6 mice indicate that, once established, cellular LTa1/1 mice provided by Dr. David Chaplin and BALB/c and C57Bl/6
mice (Jackson Laboratories, Bar Harbor,ME) werebred in our animalorganization in LN does not require sustained LTb-R
facility. For some experiments, gd 14 timed pregnant BALB/c miceengagement, in contrast with the dramatically altered
were purchased (Jackson). For experiments on adult animals, 6- tocellular organization in the spleen (Mackay et al., 1997).
8-week-old female BALB/c and C57Bl/6 mice (Jackson) were used.Strikingly, B cell follicles are maintained in LN of LTb-R-
Ig-treated adult mice despite the loss of FDC networks Monoclonal Antibodies, IgG1-Fusion Proteins, and Cytokines
(Mackay and Browning, 1998). Therefore, while the The generation of LT-specific MAbs and fusion proteins used in this
maintenance of splenic B cell follicular organization and study has been described previously (Browning et al., 1997; Mackay
FDC networks are mutually regulated and appear to et al., 1997b). In brief, fusion proteins were comprised of the extra-
cellular domain of murine LTb-R (LTb-R-Ig), murine TNF-R55 (TNF-require LTab/LTb-R engagement, LN B cell follicular
R55-Ig), or human LFA-3 (LFA-3-Ig) fused to the hinge, CH2, andorganization remains functionally independent of LTb-R
CH3 domains of human IgG1. MAbs were raised in Armenian ham-signaling and FDC networks.
sters that had been immunized with purified murine LTab or protein-
In contrast with our results using LTb-R-Ig, treatment A-coupled recombinant LTb-R-Ig fusion protein. TN3, the blocking
of adult mice with TNF-R55-Ig caused effects on LN MAb specific for TNF (Sheehan et al., 1989), was generously pro-
organization that closely resembled those seen in TNF- vided by Dr. Robert Schreiber. The hybridoma secreting the control
anti-KLH Armenian hamster Ig Ha4/8 was obtained from Dr. DonnaR552/2 and TNF2/2 mice (Pasparakis et al., 1996, 1997;
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